PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity

Pablo Aviles(PharmaMar (Spain)), Carmen Cuevas(LETIPharma (Spain))
Molecular Cancer Therapeutics
January 2, 2026
Cited by 2


Related Papers

No related papers found

Powered by citation graph analysis